Last edition
News about "Brett P Monia"
US FDA Approves GSK's Hibsago for Chronic Hepatitis B
The US FDA has approved GSK’s Hibsago (bepirovirsen) is for chronic hepatitis B, with phase 3 data showing improved functional cure rates after 6 months of treatment.
Brett P Monia | 23/10/2026 | By News Bureau
EU Recommends Ionis Pharma's TRYNGOLZA for CHMP Approval
Ionis Pharma's TRYNGOLZA has received CHMP recommendation for EU approval to treat severe hypertriglyceridemia, potentially becoming the first RNA-targeted therapy.
Brett P Monia | 17/10/2026 | By News Bureau
US FDA Approves ZANVASTRO as First Disease-Modifying Treatment for Alexander Disease
The US Food and Drug Administration (FDA) approves ZANVASTRO (zilganersen) as the first disease-modifying treatment for Alexander Disease (AxD) in pediatric and adult patients.
Brett P Monia | 05/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy